INS and diabetes mellitus: The mechanisms of glucocorticoid-induced DM include a decrease in peripheral insulin sensitivity and/or weight gain, increased glucose production due to stimulation of hepatic gluconeogenesis, destruction of pancreatic cells leading to β-cell damage and β-cell dysfunction, impaired insulin release, inhibited glyceroneogenesis, and increased fatty acid levels [189].